Skip To The Main Content

Five Critical Endotoxin Testing Concerns


As pharmaceutical manufacturing processes continue to become more streamlined and therapy delivery continues to evolve, so has endotoxin control. Five topics in particular have dominated recent discussions around endotoxin control: low endotoxin recovery, non-LAL detection methods, modulating impurities, data integrity and depyrogenation.

You need to Login to view the full article. Please Login. Not a Member? Join today!

PDA Members Save Substantially